SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-16-019249
Filing Date
2016-12-08
Accepted
2016-12-08 12:44:20
Documents
4
Period of Report
2016-12-08
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT f8k120816_soligenix.htm 8-K 32849
2 PRESS RELEASE, SOLIGENIX ANNOUNCES INVESTOR WEBCAST EVENT f8k120816ex99i_soligenix.htm EX-99.1 32539
3 PRESS RELEASE, SOLIGENIX ANNOUNCES POSITIVE LONG-TERM FOLLOW-UP RESULTS FROM ITS f8k120816ex99ii_soligenix.htm EX-99.2 31446
4 GRAPHIC ex99i_001.jpg GRAPHIC 21870
  Complete submission text file 0001213900-16-019249.txt   128513
Mailing Address 29 EMMONS DRIVE SUITE C-10 PRINCETON NJ 08540
Business Address 29 EMMONS DRIVE SUITE C-10 PRINCETON NJ 08540 609-538-8200
SOLIGENIX, INC. (Filer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-16929 | Film No.: 162040925
SIC: 2834 Pharmaceutical Preparations